Chemoinformaics analysis of Docosane (CAS) n-Docosane -
| Molecular Weight | 310.61 | nRot | 19 |
| Heavy Atom Molecular Weight | 264.242 | nRig | 0 |
| Exact Molecular Weight | 310.36 | nRing | 0 |
| Solubility: LogS | -7.548 | nHRing | 0 |
| Solubility: LogP | 10.82 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 67.4125 |
| nHD | 0 | BPOL | 46.1475 |
| QED | 0.209 |
| Synth | 1.059 |
| Natural Product Likeliness | 0.111 |
| NR-PPAR-gamma | 0.064 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -5.105 |
| MDCK | 0.00000541 |
| BBB | 0.021 |
| PPB | 0.985379 |
| VDSS | 4.533 |
| FU | 0.0117585 |
| CYP1A2-inh | 0.079 |
| CYP1A2-sub | 0.156 |
| CYP2c19-inh | 0.202 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.964 |
| CYP2d6-inh | 0.178 |
| CYP2d6-sub | 0.031 |
| CYP3a4-inh | 0.168 |
| CYP3a4-sub | 0.024 |
| CL | 4.464 |
| T12 | 0.022 |
| hERG | 0.353 |
| Ames | 0.008 |
| ROA | 0.022 |
| SkinSen | 0.968 |
| Carcinogencity | 0.023 |
| EI | 0.93 |
| Respiratory | 0.351 |
| NR-Aromatase | 0.083 |
| Antiviral | No |
| Prediction | 0.693575 |